Global optical biopsy market value is anticipated to grow with an impressive CAGR during the forecast years on the backbone of technological advancement in the diagnostic medicine. Growing demand for the highly defined imaging and 3D visualization of the endoscopic diagnostic surface for the expert to identify and diagnose the condition with clear details, further drives the growth of the global optical biopsy market in the upcoming five years. Growing instances of the chronic diseases and infectious diseases that demands detailed visualization for efficient diagnostic and timely treatment advances the growth of the global optical biopsy market in the next five years. Growing demand for non-invasive and minimally invasive diagnostic procedures further support the growth of the global optical biopsy market in the future five years.
The term “optical biopsy” refers to methods that use the properties of light to enable the operator to make an instant diagnosis at endoscopy, previously possible only by using histological or cytological analysis. Endoscopic diagnosis relies heavily over ability of the operator to visualize abnormal patterns in the image created by light reflected from the mucosal surface of the gastrointestinal tract. Some of the major optical biopsy techniques for the diagnosis includes fluorescence endoscopy, optical coherence tomography, confocal micro-endoscopy, and molecular imaging.
Growing Demand For Endoscopic Diagnosis Drives Market Growth
Surge in the instances of chronic diseases mostly in the gastrointestinal tract like peptic ulcer disease, gastritis, gastroenteritis, celiac disease, Crohn's disease, gallstones, fecal incontinence, etc. drives the growth of the global optical biopsy market in the upcoming five years. Endoscopic diagnosis becomes highly important in the case of these diseases since the effective diagnosis depends on the how much clear visuals are provided to the diagnostic expert thereby providing appropriate treatment, thus aiding the growth of the global optical biopsy market in the next five years.
In the year 2021, 2,281,658 new cancer cases surfaced in the United States alone
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
The global optical biopsy market segmentation is based on technique, application, end user, regional distribution, and competitive landscape. Based on technique, the market is fragmented into
Company Profile
Vir Biotechnology, Inc., Mauna Kea Technologies SAS, SpectraScience, Inc., PENTAX Europe GmbH, Compact Imaging, Inc., NinePoint Medical, Inc., Precision Biopsy LLC, VivaScope GmbH, LighTopTech Corp., Scinvivo B.V., are enlisted in a partial list of major market players of the global optical biopsy market.
Attribute | Details |
Base Year | 2021 |
Historical Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Technique · Application · End User |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, Australia, South Korea, New Zealand, Germany, France, United Kingdom, Spain, Italy, Netherlands, Denmark, Ireland, Belgium, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE, Turkey. |
Key companies profiled | Vir Biotechnology, Inc., Mauna Kea Technologies SAS, SpectraScience, Inc., PENTAX Europe GmbH, Compact Imaging, Inc., NinePoint Medical, Inc., Precision Biopsy LLC, VivaScope GmbH, LighTopTech Corp., Scinvivo B.V. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |